DE69909897D1 - Nachweis von Antikörpern gegen FIV unter Benutzung von ENV/GAG Polypeptiden - Google Patents

Nachweis von Antikörpern gegen FIV unter Benutzung von ENV/GAG Polypeptiden

Info

Publication number
DE69909897D1
DE69909897D1 DE69909897T DE69909897T DE69909897D1 DE 69909897 D1 DE69909897 D1 DE 69909897D1 DE 69909897 T DE69909897 T DE 69909897T DE 69909897 T DE69909897 T DE 69909897T DE 69909897 D1 DE69909897 D1 DE 69909897D1
Authority
DE
Germany
Prior art keywords
env
fiv
detection
antibodies against
against fiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69909897T
Other languages
English (en)
Other versions
DE69909897T2 (de
Inventor
Randall G Groat
Brion Mermer
Thomas P O'connor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idexx Laboratories Inc
Original Assignee
Idexx Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Laboratories Inc filed Critical Idexx Laboratories Inc
Publication of DE69909897D1 publication Critical patent/DE69909897D1/de
Application granted granted Critical
Publication of DE69909897T2 publication Critical patent/DE69909897T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69909897T 1998-05-15 1999-05-14 Nachweis von Antikörpern gegen FIV unter Benutzung von ENV/GAG Polypeptiden Expired - Lifetime DE69909897T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8561598P 1998-05-15 1998-05-15
US85615P 1998-05-15
US09/089,878 US6458528B1 (en) 1998-05-15 1998-06-03 Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
US89878 1998-06-03

Publications (2)

Publication Number Publication Date
DE69909897D1 true DE69909897D1 (de) 2003-09-04
DE69909897T2 DE69909897T2 (de) 2004-05-27

Family

ID=26772914

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69909897T Expired - Lifetime DE69909897T2 (de) 1998-05-15 1999-05-14 Nachweis von Antikörpern gegen FIV unter Benutzung von ENV/GAG Polypeptiden

Country Status (8)

Country Link
US (1) US6458528B1 (de)
EP (1) EP0962774B1 (de)
JP (1) JP3374101B2 (de)
AT (1) ATE246359T1 (de)
AU (1) AU754309B2 (de)
CA (1) CA2271449C (de)
DE (1) DE69909897T2 (de)
ES (1) ES2200472T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219725A (en) * 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
AU2005267607B8 (en) * 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
ATE435425T1 (de) 2003-09-11 2009-07-15 Idexx Lab Inc Verfahren zum nachweis des felinen immunschwächevirus
WO2005062053A2 (en) * 2003-12-18 2005-07-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
CA2556141A1 (en) * 2004-02-19 2005-09-01 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1761564A1 (de) * 2004-06-30 2007-03-14 Idexx Laboratories, Inc. Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
CA2576930C (en) * 2004-06-30 2011-06-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
KR101069391B1 (ko) * 2008-08-25 2011-09-30 베트올 (주) 고양이 레트로바이러스 탐지용 항체, 및 이를 포함하는 면역탐지키트
WO2011123781A1 (en) * 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016143A (en) * 1971-12-07 1977-04-05 Bayer Aktiengesellschaft Polyurethanes based on aromatic polyamines
US4514505A (en) 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
US4743678A (en) 1983-04-27 1988-05-10 President And Fellows Of Harvard College Method and products for detection of human T cell leukemia virus
US4939096A (en) 1986-09-10 1990-07-03 Idexx, Corp. Method and apparatus for assaying whole blood
US4965187A (en) 1986-09-10 1990-10-23 Idexx Corporation Method and apparatus for assaying whole blood
US6107077A (en) 1987-08-26 2000-08-22 Yamamoto; Janet K. Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
CA1341439C (en) 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
CA1339723C (en) 1988-01-19 1998-03-17 Philip Mcmahon Immunoassay with multiple test spots
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
US5177014A (en) 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
WO1990013573A1 (en) * 1989-05-08 1990-11-15 Idexx Corporation Polypeptides of feline t-cell lymphotropic lentivirus
EP0602046B2 (de) 1991-06-14 2007-02-21 IDEXX Laboratories Inc Detektion des immunschwäche-virus aus felis
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US5413927A (en) 1991-09-03 1995-05-09 North Carolina State University Feline immunodeficiency virus isolate NCSU1Lb
JPH09512177A (ja) * 1994-04-29 1997-12-09 ファルマシア・アンド・アップジョン・カンパニー ネコ免疫不全ウイルスワクチン
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
EP0848615B1 (de) * 1995-08-25 2005-06-08 University of Florida Research Foundation, Inc. Impfstoff gegen mehrere fiv-subtypen
US5700655A (en) 1995-11-14 1997-12-23 Idexx Laboratories, Inc. Method for quantification of biological material in a sample
GB9719357D0 (en) 1997-09-11 1997-11-12 Ortho Clinical Diagnostics Immunoassay Utilizing Two Incubations With Labelled Antigen

Also Published As

Publication number Publication date
ATE246359T1 (de) 2003-08-15
US6458528B1 (en) 2002-10-01
CA2271449C (en) 2010-07-13
JP2000002707A (ja) 2000-01-07
EP0962774A1 (de) 1999-12-08
DE69909897T2 (de) 2004-05-27
AU754309B2 (en) 2002-11-14
JP3374101B2 (ja) 2003-02-04
EP0962774B1 (de) 2003-07-30
CA2271449A1 (en) 1999-11-15
AU2806799A (en) 1999-11-25
ES2200472T3 (es) 2004-03-01

Similar Documents

Publication Publication Date Title
DE69909897D1 (de) Nachweis von Antikörpern gegen FIV unter Benutzung von ENV/GAG Polypeptiden
AU600466B2 (en) Htlv-iii envelope peptides
AU637097B2 (en) Process for preparing an improved western blot immunoassay
DE68928834D1 (de) Monoklonale antikörper gegen katzen-t-lymphotropes lentivirus
DE68927665D1 (de) Von synthetischer DNS abgeleitete rekombinante HIV-1-Antigene
DE68927025D1 (de) HIV-2-Virusvarianten
EP1475442A3 (de) Lymphotropische Polypeptide von dem Lentivirus von den T-zellen der Katze
DE3784484D1 (de) Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz.
DE3789333D1 (de) Menschlicher monoklonaler Antikörper gegen Lymphadenopathie assozierten Virus.
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
DE68910577D1 (de) Mittel gegen den AIDS-Virus.
DK637988A (da) Rekombinante polypeptider
KR900004731A (ko) 아포빈카민산 유도체
ATE219520T1 (de) Vakzine gegen katzenleukämievirus
DE69523055D1 (de) T-zellen stimulierendes protein von pestivirus
AU5118890A (en) Immunoassay for antibodies to hiv
CHEN et al. Identification of a recombinant HTLV-II envelope protein for serological detection of HTLV-II carriers
آصف جان مان فطاني Relative quantitation of HIV-1 proviral DNA amplified using the polymerase chain reaction
MX9707020A (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
DK697188D0 (da) Fremgangsmaade til detektering af antistof mod hiv (human immunodeficiency virus)